Home
|
About us
|
Kuick Reseach In News
|
Contact Us
Services
Syndicated Research
Custom Research
Data Collection
Competitor Tracking
Consumer Behavior Studies
Project Financing
Orphan Drug Intelligence
Industry Reports
US Drug Pricing Insight
Retail & Consumer Goods
Pharmaceutical & Healthcare
Information Communication Technology
Energy & Power
Banking- Financial Services & Insurance
Automotive
Orphan Drug Intelligence
Oncology Pipeline Intelligence
US Generic Drug Market Insight
White Papers
Global B Cell Lymphoma Market and Clinical Pipeline Insight 2022
No. of Pages:
303
Publish Date:
April-2017
Category:
Pharmaceutical and Healthcare
Electronic Access - Single User License
$2400
Buy Now
CD-ROM Mail Delivery
$2800
Buy Now
Hard Copy Mail Delivery
$3300
Buy Now
Electronic Access - Multi-User License
$4800
Buy Now
Buy USD 20,000 Worth Of Reports (Single User/Multi User License) In USD 8000 Only
Description
Table of Content
List of Figures & Table
Sample Request
Payment Request
Coming Soon.....
1. Introduction to B Cell Lymphoma
1.1 Outline
1.1.1 Non-Hodgkin’s Lymphoma
1.1.2 Hodgkin’s Lymphoma
1.2 Classification of the B Cell lymphoma
1.2.1 Diffuse Large B Cell Lymphoma
1.2.2 Follicular Lymphoma
1.2.3 Mantle Cell Lymphoma
1.2.4 Burkitt Lymphoma
1.3 Stages of B Cell Lymphoma
2. Role of B Cell Receptor for Lymphoma Development
2.1 Diffuse Large B Cell Lymphoma
2.2 Mantle Cell Lymphoma
2.3 Burkitt Lymphoma
3. Non-Hodgkin Lymphoma Risk Factors
3.1 Overview of Risk Factors
3.1.1 Infections
3.1.2 Weakened Immune System
3.1.3 Exposure to Radiation
3.1.4 Exposure to Chemicals
3.2 Causes of Non-Hodgkin Lymphoma
4. Strategies for B Cell Lymphoma Targeting Therapies
4.1 Current Strategies
4.1.1 Bruton’s Tyrosine Kinase (BTK)
4.1.2 Phosphoinositide 3-Kinase anddelta; (PI3Ks)
4.1.3 Spleen Tyrosine Kinase (SYK)
4.2 Next Generation Strategies for the Vaccine Therapy
4.2.1 Membrane Proteoliposomal Vaccine
4.2.2 Cytotoxic Therapies
5. Diagnosis of B Cell Lymphoma
5.1 Traditional Methods of Detection
5.1.1 Biopsy Method
5.1.2 Flow Cytometry
5.1.3 Molecular Genetic Tests
5.1.4 Positron Emission Tomography (PET) Scan
5.2 New Insights for Diagnosis of B Cell Lymphoma
5.2.1 Genomic Studies in the Diagnosis
5.2.2 Next Generation Sequencing
5.3 Biomarker in B Cell Malignancies
5.3.1 MicroRNA-155
5.3.2 B Cell Markers
6. Approaches for the Treatment B Cell Lymphoma
6.1 Chemotherapy
6.2 Radiation Therapy
7. Targeted Therapy Drugs for B Cell Lymphoma
7.1 Proteasome Inhibitors
7.2 Anti-CD22 Antibody Epratuzumab
7.3 Immunomodulators
7.4 Fostamatinib Disodium (Syk Inhibitor)
7.5 Membrane Target of Rapamycin (mTOR)
8. Global B Cell Lymphoma Market Overview
8.1 Current Scenario
8.2 Prevalence
8.3 B Cell Lymphoma Clinical Pipeline Overview
9. Global B Cell Lymphoma Market Dynamics
9.1 Accelerative Parameters
9.2 Challenges to the Market Growth
10. Global B Cell Lymphoma Market Future Scenario
11. Global B Cell Lymphoma Clinical Pipeline by Company and Phase
11.1 Research
11.2 Preclinical
11.3 Clinical
11.4 Phase-I
11.5 Phase-I/II
11.6 Phase-II
11.7 Phase-II/III
11.8 Phase-III
11.9 Preregistration
11.10 Registered
12. Marketed B Cell Lymphoma Clinical Insight
12.1 Rituximab (MabThera and Rituxan)
12.2 Rituximab Biosimilar (Novex)
12.3 Rituximab Biosimilar (Maball)
13. Competitive Landscape
13.1 Abbott Laboratories
13.2 Biogen Idec
13.3 Celgene Corporation
13.4 Genmab
13.5 Hetero Drugs
13.6 ImmunoGen
13.7 Incyte Corporation
13.8 mAbxience
13.9 Merck
13.10 Millennium Pharmaceuticals
13.11 Ono Pharmaceutical
13.12 Sandoz
13.13 Seattle Genetics
13.14 Xencor
Figure 1-1: Types of B Cell Lymphoma
Figure 1-2: B Cell Lymphoma Stages
Figure 2-1: B Cell Receptor in Diffuse Large B Cell Lymphoma
Figure 2-2: B Cell Receptor Signaling Pathway in Mantle Cell Lymphoma
Figure 3-1: Risk Factors Associated with B Cell Lymphoma
Figure 4-1: Bruton’s Tyrosine Kinase Pathway for Targeting
Figure 4-2: Phosphoinositide 3-Kinase anddelta; as Targeting Therapy
Figure 4-3: Spleen Tyrosine Kinase for Targeting
Figure 5-1: Traditional Methods for Diagnosis of B Cell Lymphoma
Figure 5-2: Noval Techniques for Detection
Figure 6-1: Approaches for the Treatment of B Cell Lymphoma
Figure 8-1: Global - Non-Hodgkin Lymphoma Market (US$ Billion), 2016 - 2022
Figure 8-2: Global - Hodgkin Lymphoma Market (US$ Million), 2016 - 2022
Figure 8-3: Survival Rate of Non-Hodgkin Lymphoma, % (5, 10, 15 Years)
Figure 8-4: Early Stage and Advance Stage Survival Rate, %
Figure 8-5: Estimated Cases of Non-Hodgkin Lymphoma, 100,000 Persons
Figure 8-6: US - B Cell Lymphoma Incidence
Figure 8-7: UK - Diagnosed Cases in Males and Females
Figure 8-8: UK - Mortality Cases in Males and Females
Figure 8-9: India - Incidence Rate in Males and Females
Figure 8-10: Global - B Cell Lymphoma Clinical Pipeline by Phase (%), 2017 till 2022
Figure 8-11: Global -B Cell Lymphoma Clinical Pipeline by Phase (Number), 2017 till 2022
Figure 8-12: Global - Discontinued and Suspended B Cell Lymphoma Drugs in Clinical Pipeline (%), 2017 till 2022
Figure 8-13: Global - Discontinued and Suspended B Cell Lymphoma Drugs in Clinical Pipeline (Number), 2017 till 2022
Figure 9-1: Market Drivers of B cell Lymphoma
Figure 9-2: Challenges to the Growth of the Market
Report Title:
Name:
Email address:
Job title:
Organisation:
Contact number:
Country:
Select Country
United States
United Kingdom
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Chad
Chile
China
Christmas Island
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Cote D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guinea
Guinea-bissau
Guyana
Haiti
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Moldova, Republic of
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russian Federation
Rwanda
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Tajikistan
Thailand
Timor-leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Submit
Payment Request
Report Title:
Name:
Email address:
Job title:
Organisation:
Contact number:
Country:
Select Country
United States
United Kingdom
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Chad
Chile
China
Christmas Island
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Cote D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guinea
Guinea-bissau
Guyana
Haiti
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Moldova, Republic of
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russian Federation
Rwanda
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Tajikistan
Thailand
Timor-leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Submit
Need custom market research solution? We can help you with that too.
Contact us